title: Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease.
abstract: Although patients with impaired glucose tolerance (IGT) are at increased atherothrombotic risk, it is unclear how antiplatelet drugs act in patients with IGT. The aim of this study was to investigate the pharmacodynamic response to clopidogrel in patients with IGT and insulin resistance (IR). A 75 g oral glucose tolerance test was performed in 65 coronary artery disease (CAD) patients on aspirin and clopidogrel therapy. Platelet function tests were assessed at 3 time-points by light transmittance aggregometry using ADP (5 and 20 μmol/L) stimuli. 30 patients had IGT and 35 normal glucose tolerance (NGT). Among them, 13 patients showed IR. Following ADP stimuli, patients with IGT showed significantly higher maximal platelet aggregation at each time point than those with NGT patients. This resulted in greater high on-treatment platelet reactivity (HPR) rates at each time point in IGT patients (53.3-36.7 vs. 14.3-11.4 %, p < 0.05). A multivariable logistic regression analysis showed that IGT status was the strongest predictor of HPR (odds ratio 7.54, 95 % CI 1.95-29.1, p = 0.003). Following a glucose load, profiles of platelet reactivity varied according to IR status, with minimal changes over time in patients with IR, while there was a significant reduction in the non-IR patients. In aspirin and clopidogrel-treated patients with CAD, IGT is associated with enhanced platelet reactivity and increased rates of HPR compared with NGT patients. These findings suggest the presence of platelet dysfunction in patients with IGT, which may be attributed to the presence of IR.
authors: Division of Cardiology, Department of Internal Medicine, Kinki University Faculty of Medicine, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan.
authors: Masafumi
authors: M
authors: Ueno
authors: Kosuke
authors: K
authors: Fujita
authors: Hiroyuki
authors: H
authors: Yamamoto
authors: Tomoyuki
authors: T
authors: Ikeda
authors: Tatsuya
authors: T
authors: Suga
authors: Kenji
authors: K
authors: Yamaji
authors: Shinichiro
authors: S
authors: Ikuta
authors: Kazuhiro
authors: K
authors: Kobuke
authors: Yoshitaka
authors: Y
authors: Iwanaga
authors: Dominick J
authors: DJ
authors: Angiolillo
authors: Shunichi
authors: S
authors: Miyazaki
mesh_terms: D000368:Aged; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000097:blood / Q000188:drug therapy; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D013997:Time Factors
chemical_list: D000077144:Clopidogrel; D013988:Ticlopidine
references: Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
references: 24357215
references: Diabetes Care. 2002 Dec;25(12):2244-8
references: 12453968
references: Arch Intern Med. 2001 Feb 12;161(3):397-405
references: 11176766
references: J Am Coll Cardiol. 2007 Apr 10;49(14):1505-16
references: 17418288
references: Thromb Haemost. 2009 Jul;102(1):7-14
references: 19572061
references: Circulation. 2007 Feb 13;115(6):708-16
references: 17261652
references: Diabetes. 2005 Aug;54(8):2430-5
references: 16046311
references: Thromb Haemost. 2008 Jul;100(1):76-82
references: 18612541
references: Thromb Haemost. 2008 Mar;99(3):637-9
references: 18327417
references: J Thromb Haemost. 2005 Oct;3(10):2149-53
references: 16194192
references: Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):417-22
references: 16339499
references: Diabetes Care. 1999 Jun;22(6):920-4
references: 10372242
references: N Engl J Med. 2008 Jun 12;358(24):2545-59
references: 18539917
references: Platelets. 2014;25(2):102-10
references: 23527528
references: Lancet. 2002 Jun 22;359(9324):2140-4
references: 12090978
references: J Am Coll Cardiol. 2006 Jul 18;48(2):298-304
references: 16843179
references: Diabetologia. 1993 Nov;36(11):1198-203
references: 8270136
references: N Engl J Med. 2009 Jan 22;360(4):354-62
references: 19106084
references: Diabetes Care. 2002 Oct;25(10):1845-50
references: 12351489
references: J Am Coll Cardiol. 2007 Oct 16;50(16):1541-7
references: 17936152
references: Thromb Haemost. 2012 Nov;108(5):930-6
references: 22782352
references: Br J Haematol. 2006 May;133(3):315-22
references: 16643434
references: Diabetes Care. 2007 Feb;30(2):325-31
references: 17259502
references: J Biol Chem. 2004 Jan 30;279(5):3254-64
references: 14602724
references: J Am Coll Cardiol. 2010 Sep 14;56(12):919-33
references: 20828644
references: J Am Coll Cardiol. 2011 Jun 28;58(1):30-9
references: 21700086
references: Nat Rev Cardiol. 2015 Jan;12(1):30-47
references: 25286881
references: Am Heart J. 2004 Jun;147(6):e25
references: 15199366
references: Eur Heart J. 2002 Aug;23(16):1267-75
references: 12175663
references: Blood. 2004 Sep 1;104(5):1361-8
references: 15130939
references: Thromb Haemost. 2005 Mar;93(3):517-26
references: 15735804
references: Eur Heart J. 2008 Jan;29(2):166-76
references: 18156614
references: J Clin Pharmacol. 2010 Aug;50(8):929-40
references: 20173083
references: Eur Heart J. 2011 Apr;32(7):838-46
references: 21252171
references: Atherosclerosis. 2008 Apr;197(2):718-24
references: 17765245
references: J Thromb Haemost. 2004 Aug;2(8):1282-91
references: 15304032
references: J Am Coll Cardiol. 2014 Sep 9;64(10):1005-14
references: 25190236
references: Cardiovasc Res. 2005 Mar 1;65(4):907-12
references: 15721871
references: Circulation. 2011 Feb 22;123(7):798-813
references: 21343595
references: Diabetes. 2012 Sep;61(9):2380-4
references: 22688337
references: Diabetologia. 1985 Jul;28(7):412-9
references: 3899825